Bente Glintborg

Bente Glintborg

Clinical Associate Professor

Member of:

  • Internal Medicine: Rheumatology


Publication year:
All
31 - 40 out of 75Page size: 10
Sort by: 1st author
  1. Published

    Does a mandatory non-medical switch from originator to biosimilar etanercept lead to increase in healthcare use and costs?

    Glintborg, Bente, Ibsen, R., Bilbo, R. E. Q., Hetland, Merete Lund & Kjellberg, J., 2019, In: RMD Open. 5, 2, 9 p., e001016.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    OP0324 Risk of serious infections in rheumatoid arthritis patients treated with abatacept, rituximab and tocilizumab in denmark and sweden

    Grøn, K. L., Arkema, E., Glintborg, Bente, Mehnert, F., Østergaard, M., Dreyer, L., Nørgaard, M., Krogh, N. S., Askling, J. & Heltand, M., 2018, p. 208-208. 1 p.

    Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

  3. Published

    DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL

    Grøn, K., Glintborg, Bente, Nørgaard, M., Mehnert, F., Stergaard, M., Dreyer, L., Krogh, N. S., Bjørner, Jakob Bue & Hetland, Merete Lund, 2019, In: Annals of the Rheumatic Diseases. 78, Suppl 2, p. 1391-1391 SAT0595.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  4. Published

    OVERALL INFECTION RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT, RITUXIMAB AND TOCILIZUMAB: AN OBSERVATIONAL COHORT STUDY

    Grøn, K., Glintborg, Bente, Mehnert, F., Østergaard, Mikkel, Dreyer, L., Nørgaard, M., Krogh, N. S. & Hetland, Merete Lund, 2019, In: Annals of the Rheumatic Diseases. 78, Suppl 2, p. 630 THU0667.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  5. Published

    Comparative Effectiveness of Certolizumab Pegol, Abatacept, and Biosimilar Infliximab in Patients With Rheumatoid Arthritis Treated in Routine Care: Observational Data From the Danish DANBIO Registry Emulating a Randomized Trial

    Grøn, K. L., Glintborg, Bente, Nørgaard, M., Mehnert, F., Østergaard, Mikkel, Dreyer, L., Krogh, N. S., Bjørner, Jakob Bue & Hetland, Merete Lund, 2019, In: Arthritis & Rheumatology. 71, 12, p. 1997-2004 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Overall infection risk in rheumatoid arthritis during treatment with abatacept, rituximab and tocilizumab; an observational cohort study

    Grøn, K. L., Glintborg, Bente, Nørgaard, M., Mehnert, F., Østergaard, Mikkel, Dreyer, L., Krogh, N. S. & Hetland, Merete Lund, 2020, In: Rheumatology. 59, 8, p. 1949-1956 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden

    Grøn, K. L., Arkema, E. V., Glintborg, Bente, Mehnert, F., Østergaard, Mikkel, Dreyer, L., Nørgaard, M., Krogh, N. S., Askling, J. & Hetland, Merete Lund, 2019, In: Annals of the Rheumatic Diseases. 78, 3, p. 320-327

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Neoehrlichia mikurensis is uncommon in rheumatological patients receiving tumour necrosis factor inhibitors and in blood donors: a retrospective cohort study

    Gynthersen, R., Ørbæk, M., Høgdall, Estrid Vilma Solyom, Glintborg, Bente, Ostrowski, Sisse Rye, Harritshøj, Lene Holm, Hetland, Merete Lund, Lebech, Anne-Mette & Mens, H., 2024, In: RMD Open. 10, 1, 6 p., e003660.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: Results from the EuroSpA Research Collaboration Network

    Hellamand, P., Van De Sande, M., Ørnbjerg, L. M., Klausch, T., Nurmohamed, M. T., Van Vollenhoven, R. F., Nordström, D., Hokkanen, A. M., Santos, M. J., Vieira-Sousa, E., Loft, A. G., Glintborg, B., Hetland, M. L., Lindström, U., Wallman, J. K., Michelsen, B., Klami Kristianslund, E., Ciurea, A., Nissen, M. S., Codreanu, C. & 17 others, Mogosan, C., Macfarlane, G. J., Rotariu, O., Rotar, Z., Tomšič, M., Castrejon, I., Otero-Varela, L., Gudbjornsson, B., Geirsson, A. J., Vencovský, J., Pavelka, K., Gulle, S., Zengin, B., Iannone, F., Foti, R., Østergaard, Mikkel & Van Der Horst-Bruinsma, I., 2023, In: RMD Open. 9, 4, 14 p., e003325.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network

    Hellamand, P., van de Sande, M. G. H., Ørnbjerg, L. M., Klausch, T., Eklund, K. K., Relas, H., Santos, M. J., Vieira-Sousa, E., Loft, A. G., Glintborg, B., Østergaard, M., Lindström, U., Wallman, J. K., Michelsen, B., Fagerli, K. M., Castrejón, I., Gudbjornsson, B., Love, T. J., Vencovský, J., Nekvindová, L. & 13 others, Rotar, Ž., Tomšič, M., Díaz-González, F., Kenar, G., Tuğsal, H. Y., Iannone, F., Ramonda, R., Codreanu, C., Mogosan, C., Nissen, M. J., Möller, B., Hetland, Merete Lund & van der Horst-Bruinsma, I. E., 2024, In: Arthritis and Rheumatology. 76, 4, p. 587-598 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 Next

ID: 212553036